Regeneron shareholders elect directors, approve board declassification; two supermajority amendments fail

REGENERON PHARMACEUTICALS, INC.

Class I directors elected: Bassler (87.3M for, 18.6M against), Brown (77.0M for, 28.9M against), Schleifer (99.3M for), Yancopoulos (101.4M for).
Board declassification amendment approved (85.7M for, 20.2M against, 5.6M broker non-votes).
Proposal to amend Class A stock conversion supermajority vote failed (0 Class A for, 18.1M against).
Proposal to remove 80% supermajority for director removal also failed (85.5M for, 20.4M against, not meeting required vote).
Advisory vote on executive compensation approved (98.8M for, 7.1M against); auditor ratification also passed (105.5M for).

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.